Related Experiment Video

Updated: Jun 14, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.4K

Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis

Yi Chen1,2,3, Hefang Xiao1,2,3, Zirui Liu1,2,3

  • 1Department of Orthopedics, Lanzhou University Second Hospital, Lanzhou 730030, China.

Biomolecules
|August 29, 2024
PubMed

Insights

Osteoporosis (OP) is a bone disease affecting bone mass and microarchitecture. Sirtuin1 (SIRT1) plays a key role in bone metabolism and homeostasis, offering potential therapeutic targets for OP.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Metabolic Bone Diseases

Background:

  • Osteoporosis (OP) is a prevalent metabolic bone disease marked by low bone mass and microarchitectural deterioration.
  • The intricate mechanisms of bone remodeling and the regulation of bone mass are not fully understood.
  • Sirtuin1 (SIRT1), a NAD+-dependent deacetylase, influences diverse cellular processes, including inflammation, cancer, and bone metabolism.

Purpose of the Study:

  • To review the critical role of Sirtuin1 (SIRT1) in maintaining bone homeostasis.
  • To elucidate the involvement of SIRT1 in the pathogenesis of osteoporosis (OP).
  • To discuss current and future therapeutic strategies targeting SIRT1 for OP treatment.

Main Methods:

  • Literature review of studies on Sirtuin1 (SIRT1) and bone metabolism.
  • Analysis of research investigating the link between SIRT1 and osteoporosis (OP).
  • Synthesis of information on therapeutic interventions targeting SIRT1.

Main Results:

  • Sirtuin1 (SIRT1) is increasingly recognized for its significant contribution to bone metabolism and homeostasis.
  • Dysregulation of SIRT1 is implicated in the development and progression of osteoporosis (OP).
  • Targeting SIRT1 presents a promising avenue for novel OP therapeutic strategies.

Conclusions:

  • Sirtuin1 (SIRT1) is a key regulator of bone metabolism and plays a vital role in preventing osteoporosis.
  • Further research into SIRT1 pathways could lead to effective treatments for metabolic bone diseases.
  • Targeting SIRT1 offers a potential therapeutic strategy for managing osteoporosis.
Keywords:
SIRT1bone metabolismosteoporosistherapeutic interventions

More Related Videos

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates14:32

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Published on: February 27, 2016

8.3K
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy04:23

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

252

Related Concept Videos

Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.2K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K